We invite you to attend our featured presentations at TIDES Europe 2025
More detailsEnhance Peptide Manufacturing Using Backbone N-Protecting Groups
Register for this webinar to learn how backbone protection can improve efficiency and product quality in peptide manufacturing.
Learn more and register today!Alzheimer peptide vaccine: Testimonial with Tord Labuda, CEO, Alzinova AB
Learn more about the collaboration
Watch the video hereCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
28 Oct 2025 - Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract […]
Read moreCapacity expansion underway at our Ambernath facility
24 Oct 2025 - We recently announced an investment at our Ambernath facility in India—transforming it into a larger, more diverse site. This expansion is part of PolyPeptide’s strategic growth, […]
Read more